Establishing secure connection…Loading editor…Preparing document…

Employee Drug Screen Procedures

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

EMPLOYEE DRUG SCREEN PROCEDURES

Purpose and Scope

This document establishes the policy and standardized procedures for drug and alcohol screening of employees and applicants. The objective is to protect workplace safety, ensure compliance with applicable laws and contractual obligations, and provide a consistent, defensible process for specimen collection, laboratory testing, Medical Review Officer (MRO) review, record retention, and employee notification. These procedures apply to all applicants and employees in positions designated by the employer and to any individual who is subject to testing under this policy.

Definitions

"Verified Positive" means a laboratory report affirmed by the MRO that indicates the presence of a prohibited substance or metabolite, as defined in this policy. "Refusal to Test" includes failure to appear, failure to provide a specimen, adulteration or substitution of a specimen, or other conduct designed to frustrate testing.

Testing Circumstances

Employees and applicants may be required to submit to drug and/or alcohol testing under the following circumstances as applicable to their position: pre-employment, reasonable suspicion, post-accident, random selection, return-to-duty following a confirmed violation, and follow-up testing. The procedures for each testing circumstance are detailed below.

Testing Types and Substances

Testing may include urine drug screening, oral fluid testing, breath alcohol testing, and other scientifically accepted methods. Substances subject to screening include, but are not limited to: amphetamines/methamphetamines, cocaine, opioids (including heroin, morphine, codeine), THC/cannabinoids, phencyclidine (PCP), and other substances identified by the employer or required by contract. Confirmatory testing shall be performed using validated laboratory methods.

Specimen Collection and Chain of Custody

Collection will be performed by trained collection personnel following strict chain of custody protocols. The collector will verify identity, instruct the donor, and complete required documentation. Specimens will be sealed and labeled in the presence of the donor. All collection activities and custodial transfers will be documented to maintain an unbroken chain of custody from collection through laboratory analysis.

Observed Collections and Refusals

Observed collections shall be conducted when tampering or substitution is reasonably suspected or when directed by regulatory or contractual requirements. A refusal to provide a specimen, an attempt to adulterate or substitute, or other obstructive behavior will be treated as a refusal to test and may result in disciplinary action up to and including termination.

Laboratory Testing and Medical Review

All specimens designated for confirmation testing will be analyzed by certified laboratories using validated methods. The MRO will review non-negative laboratory results, consider legitimate medical explanations, and notify the employer of verified positive results or refusals to test. The employer will not act on preliminary positive results until the MRO completes verification.

Notification, Confidentiality, and Recordkeeping

Test results and related records are confidential and will be disclosed only to supervisors and managers with a legitimate business need, to the MRO, collection and laboratory personnel, and as required by law. Records of testing, chain of custody, laboratory reports, and MRO determinations will be retained in a secure file for the period required by applicable law or company policy.

Consequences of Verified Positive or Refusal

A verified positive test, a confirmed adulterated/substituted specimen, or a refusal to test will subject the individual to disciplinary action up to and including termination. The employer may require a fitness-for-duty evaluation, treatment and rehabilitation as a condition of continued employment where permitted by law and policy. Return-to-duty and follow-up testing protocols will apply as set forth in this document.

Employee Rights and Appeals

Employees have the right to provide information regarding prescription or over-the-counter medications to the MRO for consideration. Where applicable, employees may request the split specimen be tested at an independent laboratory in accordance with procedures for handling and timelines established by the MRO or regulatory requirements. Disputes regarding procedural errors or test integrity may be raised through the employer's established grievance procedure.

Procedural Steps for Specific Test Events

Pre-employment: Applicants selected for testing must report to the designated collection site prior to the commencement of employment. Random: Employees selected by an objective, non-discriminatory process must report immediately for collection. Reasonable suspicion: Supervisors must document observed conduct that gives rise to reasonable suspicion; the employee shall be transported to the collection site in a timely manner. Post-accident: Testing following an incident shall occur as soon as practicable and before the employee resumes safety-sensitive duties when feasible.

Authorization and Employee Consent

By acknowledging below, the employee or applicant consents to submit to collection and testing as required by this policy and authorizes release of test results to the employer and MRO for purposes of employment decisions and compliance.

Personal Information

Position Information

Employment History (Most Recent First)

Education

References (Professional)

Acknowledgment of Policy and Consent

I have read and understand the Employee Drug Screen Procedures, including testing circumstances, collection procedures, confidentiality, and consequences for a verified positive test or refusal to test. I consent to submit to drug and/or alcohol screening as required by this policy and authorize the release of test information to the employer and MRO as necessary for employment decisions.

Applicant Certification and Authorization

I certify that all information provided in this form is true and complete to the best of my knowledge. I understand that false statements, omissions, or misrepresentations may disqualify me from employment or subject me to disciplinary action. I expressly authorize the employer and its designated agents to contact my prior employers, references, and treatment providers as necessary to verify my employment history and to obtain information relevant to my fitness for duty and compliance with this drug screening policy.

I authorize previous employers and professional references to release information to the employer for the purposes described above. I understand that, where required by law, reasonable accommodation requests will be considered but do not negate the employer's right to require testing when permitted.

Acknowledgment of Receipt

By signing below, I acknowledge receipt of this policy and certify that I understand my obligations and the testing procedures described herein.

Employee Name:

Signature:

Date:

Enter text✕

Overview of Employee Drug Screen Procedures

Employee Drug Screen Procedures document a workplace process for ordering, administering, and reporting pre-employment, post-incident, random, or reasonable-suspicion drug tests. It defines who may request testing, acceptable specimen types, chain-of-custody protocols, laboratory accreditation requirements, and how results are disclosed and retained. The form captures employee identification, consent or authorization, testing reason, collector information, and test results or laboratory reports. Clear procedures reduce legal exposure, preserve evidentiary integrity, and help employers apply consistent, nondiscriminatory testing practices across roles and locations.

Why a Formal Procedure Matters

A formal Employee Drug Screen Procedures document standardizes testing steps, protects employee privacy, and supports defensible HR decisions under state and federal rules. It documents consent, chain of custody, and retention to reduce legal and regulatory risk.

Why a Formal Procedure Matters

Who Completes and Relies on These Procedures

HR, safety managers, occupational health vendors, and hiring supervisors typically use and complete drug screen procedure forms.

  • Human Resources: Manages policy, consent tracking, and appeals processing.
  • Occupational Health Clinics: Collect specimens, complete chain-of-custody, and send to certified labs.
  • Supervisors / Safety Leads: Document reasonable suspicion or incident details for testing.

Accurate completion ensures consistent enforcement and preserves records needed for audits, insurance, or legal review.

Step-by-step: Complete an Employee Drug Screen Procedures Form

Follow these sequential steps to capture required test details and maintain chain-of-custody integrity.

  • 01
    Identify Subject: Record full legal name and government ID.
  • 02
    State Reason: Select pre-employment, random, post-incident, or reasonable suspicion.
  • 03
    Collect Specimen: Document specimen type, collector name, and collection time.
  • 04
    Send to Lab: Use accredited lab; attach chain-of-custody form.

How to configure an online drug screen workflow

Common configuration settings help automate routing, notifications, and record retention.

Field Configuration
Signer Order HR → Collector → Lab reviewer
Authentication Email link with optional SMS code
Conditional Fields Show incident details only if 'reason' is post-incident
Retention Policy Set automatic archival per retention rules

Typical end-to-end flow for electronic submission

A clear eSubmission path maintains evidence and supports timely decisions.

  • Prepare Form: HR uploads and configures required fields.
  • Collect Consent: Employee signs consent electronically or on paper.
  • Capture Chain-of-Custody: Collector records specimen details and timestamps.
  • Receive Results: Lab returns report and HR records outcome.

Digital signing and platform considerations

Choose a platform that preserves audit trails, secures PHI if applicable, and supports conditional fields.

  • File Formats: Accept PDF and DOCX for compatibility.
  • Authentication Options: Email, SMS, or advanced methods for higher-risk workflows.
  • HIPAA Support: BAA availability for healthcare employers handling PHI.

Ensure integrations with HRIS or case management systems to automate record storage and access controls.

Core sections to include in professional procedures

A complete Employee Drug Screen Procedures document groups authorization, collection, testing, reporting, appeals, and retention into distinct sections.

Authorization

Consent language, scope of testing, and applicant/employee acknowledgement of policies and consequences.

Collection Protocol

Chain-of-custody, collector qualifications, specimen handling, labeling, and transport requirements.

Testing Standards

Accredited lab requirement, testing panels, cutoff levels, and confirmatory testing rules.

Result Reporting

How positive, negative, and invalid results are communicated and to whom.

Adverse Action & Appeals

Notification timelines, opportunity to provide medical explanations, and retest procedures.

Recordkeeping

Retention periods, access controls, and secure disposal procedures.

Download, storage, and accompanying documents

Include supporting forms and export options so records remain accessible and compliantly archived.

Export Formats

Save as PDF/A for long-term archival; keep original DOCX for template edits.

Supporting Forms

Attach chain-of-custody, lab receipt, consent disclosure, and MRO correspondence.

Access Controls

Limit view/edit rights to HR and designated medical reviewers.

Audit Trail

Maintain timestamps, IP addresses, and signer authentication records.

Timelines, deadlines, and processing expectations

Key dates determine when tests must be administered, when results should be reported, and when adverse actions proceed.

Specimen Collection Window:

Collect as soon as practical after incident; follow employer policy.

Laboratory Turnaround:

Initial screening typically 24–72 hours; confirmatory testing varies.

Notification Period:

Provide test outcome notice per company policy and applicable law.

Retest Request:

Allow reanalysis request within employer-specified timeframe.

Adverse Action Timing:

Wait for final MRO determination before formal disciplinary steps.

Key processing milestones for a typical drug screen

Sequential milestones ensure specimens are handled, tested, and documented in a defensible sequence.

01

Request and Consent

Obtain signed consent or authorization prior to collection.

02

Specimen Collection

Collector documents time, method, and chain-of-custody.

03

Laboratory Screening

Screening assays performed at accredited lab.

04

MRO Review

Medical Review Officer validates positives and authorizes reporting.

Common pitfalls to avoid

  • Missing or unsigned consent forms increase legal risk.
  • Incomplete chain-of-custody undermines specimen integrity.
  • Using non-accredited labs may invalidate results.
  • Inconsistent policy application invites discrimination claims.

Security and compliance items to document

Encryption: TLS 1.2/1.3 in transit
Data at Rest: AES-256 encrypted storage
HIPAA: BAA required for PHI handling
Audit Trail: Immutable signing logs retained
Access Control: Role-based access enforced
Certifications: SOC 2 Type II and ISO 27001

Penalties and legal risks of incorrect procedures

I-9 Violations: Fines $281–$2,789 per violation
1099/Tax Errors: Penalties $60–$330 per form (IRC §6721)
HIPAA Breach: Civil penalties and corrective action
Discrimination Claims: Liability for inconsistent testing
Chain Issues: Specimen rejection or evidence loss
Intentional Misconduct: Elevated penalties, possible litigation

eSignature vendor comparison for Employee Drug Screen Procedures

Compare common eSignature plan features and compliance attributes when choosing a platform for confidential drug screening workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Yes Yes Yes Yes
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

FAQs and troubleshooting for Employee Drug Screen Procedures

Answers to common questions about form completion, eSigning, confidentiality, and recordkeeping.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users